Funding cuts impacting medical research have sent shockwaves through the scientific community, jeopardizing crucial initiatives designed to ensure patient safety.The recent freeze on over $2 billion in federal research grants, particularly at Harvard, has disrupted not only clinical trials funding but also the oversight mechanisms that protect research participants.